SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-008750
Filing Date
2018-08-09
Accepted
2018-08-09 16:31:30
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q TG10Q-Q218.htm 10-Q 987855
2 EXHIBIT 10.20 exhibit10-20.htm EX-10.20 731215
3 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 16214
4 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 16122
5 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 5771
6 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 5899
  Complete submission text file 0001654954-18-008750.txt   3935928

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtx-20180630.xml EX-101.INS 440162
8 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20180630.xsd EX-101.SCH 36423
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20180630_cal.xml EX-101.CAL 43299
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20180630_def.xml EX-101.DEF 100299
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20180630_lab.xml EX-101.LAB 246394
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20180630_pre.xml EX-101.PRE 184522
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 181005528
SIC: 2834 Pharmaceutical Preparations